183 related articles for article (PubMed ID: 35256742)
1. Cancer incidence in healthy Swedish peripheral blood stem cell donors.
Pahnke S; Nygell UA; Johansson JE; Kisch A; Ljungman P; Sandstedt A; Hägglund H; Larfors G
Bone Marrow Transplant; 2022 May; 57(5):795-802. PubMed ID: 35256742
[TBL] [Abstract][Full Text] [Related]
2. Incidence of cardiovascular disease in healthy Swedish peripheral blood stem cell donors - a nationwide study.
Pahnke S; Hägglund H; Larfors G
Bone Marrow Transplant; 2024 Mar; 59(3):403-408. PubMed ID: 38212669
[TBL] [Abstract][Full Text] [Related]
3. Mobilization of autologous and allogeneic peripheral blood stem cells for transplantation in haematological malignancies using biosimilar G-CSF.
Schmitt M; Hoffmann JM; Lorenz K; Publicover A; Schmitt A; Nagler A
Vox Sang; 2016 Aug; 111(2):178-86. PubMed ID: 27509033
[TBL] [Abstract][Full Text] [Related]
4. [The incidence of malignancies and surveillance of hematopoietic stem cells donors--the results of the Haemato-Oncology Department University Hospital in Plzen (Pilsen) and Czech National Marrow Donors Registry observation].
Vokurka S; Koza V; Jungová A; Navrátilová J; Svoboda T; Jindra P; Steinerová K; Hrabětová M; Výrutová R; Novák L
Klin Onkol; 2012; 25(1):42-6. PubMed ID: 22348219
[TBL] [Abstract][Full Text] [Related]
5. [Collection of hematopoietic progenitor cells from healthy donors].
Bojanić I; Cepulić BG; Mazić S
Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
[TBL] [Abstract][Full Text] [Related]
6. Is mobilized peripheral blood comparable with bone marrow as a source of hematopoietic stem cells for allogeneic transplantation from HLA-identical sibling donors? A case-control study.
Gallardo D; de la Cámara R; Nieto JB; Espigado I; Iriondo A; Jiménez-Velasco A; Vallejo C; Martín C; Caballero D; Brunet S; Serrano D; Solano C; Ribera JM; de la Rubia J; Carreras E
Haematologica; 2009 Sep; 94(9):1282-8. PubMed ID: 19734420
[TBL] [Abstract][Full Text] [Related]
7. Stem cell collection in unmanipulated HLA-haploidentical/mismatched related transplantation with combined granulocyte-colony stimulating factor-mobilised blood and bone marrow for patients with haematologic malignancies: the impact of donor characteristics and procedural settings.
Zhang C; Chen XH; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Sun AH; Gong Y; Zeng DF; Wang QY
Transfus Med; 2010 Jun; 20(3):169-77. PubMed ID: 20136781
[TBL] [Abstract][Full Text] [Related]
8. Haematological malignancies in sibling and unrelated donors of allogeneic peripheral stem cells mobilised with G-CSF filgrastim: a transplant centre and Czech National Marrow Donors Registry experience.
Vokurka S; Koza V; Jungova A; Navratilova J; Svoboda T; Jindra P; Steinerova K; Vyrutova R
Bone Marrow Transplant; 2012 Jun; 47(6):867-8. PubMed ID: 21874056
[No Abstract] [Full Text] [Related]
9. Allogeneic peripheral blood stem cell transplantation in children with hematologic malignancies from HLA-matched siblings.
Watanabe T; Kajiume T; Abe T; Kawano Y; Iwai A; Iwai T; Takaue Y; Kuroda Y
Med Pediatr Oncol; 2000 Mar; 34(3):171-6. PubMed ID: 10696122
[TBL] [Abstract][Full Text] [Related]
10. [A pilot study of G-CSF mobilized allogeneic bone marrow cells plus peripheral blood stem cells transplantation for malignant hematological diseases].
Chen Y; Huang X; Xu L; Liu D; Zhang Y; Ren H; Guo N; Lu D
Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(19):1306-9. PubMed ID: 12509932
[TBL] [Abstract][Full Text] [Related]
11. Cost and outcome in stem cell collections in HLA-haplo identical/mismatched related transplantation with combined granulocyte-colony stimulating factor-mobilized blood and bone marrow for patients with hematologic malignancies.
Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Sun AH; Zeng DF; Wang QY
Transfus Apher Sci; 2010 Aug; 43(1):23-8. PubMed ID: 20554478
[TBL] [Abstract][Full Text] [Related]
12. Biosimilar Filgrastim (Tevagrastim, XMO2) for Allogeneic Hematopoietic Stem Cell Mobilization and Transplantation in Patients with Acute Myelogenous Leukemia/Myelodysplastic Syndromes.
Danylesko I; Sareli R; Bloom-Varda N; Yerushalmi R; Shem-Tov N; Shimoni A; Nagler A
Biol Blood Marrow Transplant; 2016 Feb; 22(2):277-283. PubMed ID: 26343949
[TBL] [Abstract][Full Text] [Related]
13. Immunological Heterogeneity of Healthy Peripheral Blood Stem Cell Donors-Effects of Granulocyte Colony-Stimulating Factor on Inflammatory Responses.
Tvedt THA; Melve GK; Tsykunova G; Ahmed AB; Brenner AK; Bruserud Ø
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30249022
[TBL] [Abstract][Full Text] [Related]
14. Follow-up of healthy donors receiving granulocyte colony-stimulating factor for peripheral blood progenitor cell mobilization and collection. Results of the Spanish Donor Registry.
de la Rubia J; de Arriba F; Arbona C; Pascual MJ; Zamora C; Insunza A; Martínez D; Paniagua C; Díaz MA; Sanz MA
Haematologica; 2008 May; 93(5):735-40. PubMed ID: 18387976
[TBL] [Abstract][Full Text] [Related]
15. Effects of granulocyte-colony stimulating factor on chromosome aneuploidy and replication asynchrony in healthy peripheral blood stem cell donors.
Hirsch B; Oseth L; Cain M; Trader E; Pulkrabek S; Lindgren B; Luo X; Clay M; Miller J; Confer D; Weisdorf D; McCullough J
Blood; 2011 Sep; 118(9):2602-8. PubMed ID: 21719598
[TBL] [Abstract][Full Text] [Related]
16. Medical and ethical considerations on hematopoietic stem cells mobilization for healthy donors.
Moalic-Allain V
Transfus Clin Biol; 2018 May; 25(2):136-143. PubMed ID: 29555414
[TBL] [Abstract][Full Text] [Related]
17. Long-Term Safety of Short-Term Administration of Filgrastim (rhG-CSF) and Leukophresis Procedure in Healthy Children: Application of Peripheral Blood Stem Cell Collection in Pediatric Donors.
Behfar M; Faghihi-Kashani S; Hosseini AS; Ghavamzadeh A; Hamidieh AA
Biol Blood Marrow Transplant; 2018 Apr; 24(4):866-870. PubMed ID: 29284143
[TBL] [Abstract][Full Text] [Related]
18. Lower platelet count with increased density of platelet antigens in granulocyte colony-stimulating factor mobilized peripheral blood stem cell donors.
Wu YF; Gu MH; Yang SH; Wang TF
J Formos Med Assoc; 2020 Jan; 119(1 Pt 2):204-210. PubMed ID: 31003920
[TBL] [Abstract][Full Text] [Related]
19. Challenge to Predict Mobilized Peripheral Blood Stem Cells on the Fourth Day of Granulocyte Colony-Stimulating Factor Treatment in Healthy Donors: Predictive Value of Basal CD34
Martino M; Gori M; Moscato T; Naso V; Ferreri A; Provenzano F; Loteta B; Sanguedolce MC; Console G; Dattola A; Pucci G; Gentile M; Morabito A; Recchia AG; Tripepi G; Pitino A
Biol Blood Marrow Transplant; 2019 Aug; 25(8):1586-1591. PubMed ID: 31002994
[TBL] [Abstract][Full Text] [Related]
20. Differences in Cellular Composition of Peripheral Blood Stem Cell Grafts from Healthy Stem Cell Donors Mobilized with Either Granulocyte Colony-Stimulating Factor (G-CSF) Alone or G-CSF and Plerixafor.
Teipel R; Oelschlägel U; Wetzko K; Schmiedgen M; Kramer M; Rücker-Braun E; Hölig K; von Bonin M; Heidrich K; Fuchs A; Ordemann R; Kroschinsky F; Bornhäuser M; Hütter G; Schmidt H; Ehninger G; Schetelig J; Heidenreich F
Biol Blood Marrow Transplant; 2018 Nov; 24(11):2171-2177. PubMed ID: 29935214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
